Literature DB >> 33835349

Comment on: Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System.

Michael Auerbach1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33835349     DOI： 10.1007/s40264-021-01058-y

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  1 in total

1.  Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System.

Authors:  Henry Trumbo; Karolina Kaluza; Syed Numan; Lawrence T Goodnough
Journal:  Drug Saf       Date:  2020-11-25       Impact factor: 5.606
  1 in total
  1 in total

1.  Authors' Reply to Michael Auerbach's Comment on: "Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System".

Authors:  Henry Trumbo; Karolina Kaluza; Syed Numan; Lawrence T Goodnough
Journal:  Drug Saf       Date:  2021-04-09       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.